The IUCD-associated incidence of Actinomyces israelii in the female genital tract.
Cervical swabs and in many cases also intrauterine contraceptive devices were examined from 973 women for the presence of Actinomyces israelii. It was detected in 11.6% of these women, the majority of whom were asymptomatic. The detection, however, of A. israelii in the female genital tract was associated with an almost 4-fold increase in the incidence of pelvic inflammatory disease (PID), indicating that colonization may progress to an infection in a small number of women. The incidence of A. israelii in the female genital tract of IUCD wearers was more than doubled when the IUCD was worn for longer than 4 years. The type of IUCD worn did not appear to be an important risk factor. Immunofluorescent staining of cervical smears identified 64% of cases. Specific culturing for A. israelii or cytological screening of Papanicolaou smears in addition were required to increase the isolation rate to nearly 90%.
Cleghorn
A G
AG
Department of Microbiology, University of Melbourne, Parkville, Victoria.
Wilkinson
R G
RG
D000190:Actinomyces / Q000302:isolation & purification*; D005260:Female; D015200:Fluoroimmunoassay; D005836:Genitalia, Female / Q000382:microbiology*; D006801:Humans; D007434:Intrauterine Devices / Q000009:adverse effects*; D065006:Papanicolaou Test; D014626:Vaginal Smears